Description
Walrycin B inhibits the walrycin response regulator (WalR). This compound exhibits antibacterial activity, altering cell wall metabolism and cell division in Bacillus and Staphylococcus.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Walrycin B inhibits the walrycin response regulator (WalR). This compound exhibits antibacterial activity, altering cell wall metabolism and cell division in Bacillus and Staphylococcus.
| Cas No. | 878419-78-4 |
|---|---|
| Purity | ≥98% |
| Formula | C14H10F3N5O2 |
| Formula Wt. | 337.26 |
| IUPAC Name | 1,6-Dimethyl-3-[4-(trifluoromethyl)phenyl]pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione |
| Solubility | DMSO: 11.5 mg/mL |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Gotoh Y, Doi A, Furuta E, et al. Novel antibacterial compounds specifically targeting the essential WalR response regulator. J Antibiot (Tokyo). 2010 Mar;63(3):127-34. PMID: 20111065.
CRTH2 inhibitor, TxA2 antagonist.
ALK inhibitor.
Bisphosphonate.
5-HT1A agonist, 5-HT1B partial agonist, 5-HT3A/...
Tetracycline; FIASMA, histamine H1, 5-HT2, mACh...
Opioid peptide; δOR agonist.
Fluoroquinolone; bacterial DNA gyrase and helic...
Mycotoxin that has structural similarity to est...
Wip1 inhibitor.
Semi-synthetic analog of taxol; microtubule dep...
c-MET and Ron inhibitor.
Imidazole; 14-α demethylase inhibitor, potenti...
Kv7 K+ channel activator, NMDA antagonist, GABA...
5-HT1B/1D agonist.
Peptide, vSrc-induced cytokine.
Synthetic progestogen, orexigenic.
Fluoroquinolone; topoisomerase IV and bacterial...
Camptothecin derivative; topoisomerase I inhibi...
Nucleoside (deoxyguanosine) analog; DNA chain t...
Triazole; 14-α demethylase inhibitor, potentia...